Assignee
SOLOMON ATLEE
US·1 granted patent·2 pending applications·0 citations·filing 2016–2023
Technology mixA61K3
Top patents by PatentIndex Score
3 records- 0153US2023414563A1Intranasal and transdermal administration of kappa-opioid-receptor agonists: salvinorin a for the treatment of neuropsychiatric and addictive disordersSOLOMON ATLEE·Filed 2023·Application pending·0 cites
- 0242US10881637B2Intranasal and transdermal administration of kappa-opioid-receptor agonists: salvinorin A for the treatment of neuropsychiatric and addictive disordersSOLOMON ATLEE·Filed 2016·Granted Jan 5, 2021·0 cites·18 claims
- 0342US2021154169A1Intranasal and transdermal administration of kappa-opioid-receptor agonists: salvinorin a for the treatment of neuropsychiatric and addictive disordersSOLOMON ATLEE·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SOLOMON ATLEE files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →